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ParaHydrogen Polarized Ethyl-[1-13C]pyruvate in Water, a
Key Substrate for Fostering the PHIP-SAH Approach to
Metabolic Imaging
Carla Carrera,[a] Eleonora Cavallari,[b] Giuseppe Digilio,[c] Oksana Bondar,[b] Silvio Aime,[b] and
Francesca Reineri*[b]
An efficient synthesis of vinyl-[1-13C]pyruvate has been reported,
from which 13C hyperpolarized (HP) ethyl-[1-13C]pyruvate has
been obtained by means of ParaHydrogen Induced Polarization
(PHIP). Due to the intrinsic lability of pyruvate, which leads
quickly to degradation of the reaction mixture even under mild
reaction conditions, the vinyl-ester has been synthesized
through the intermediacy of a more stable ketal derivative. 13C
and 1H hyperpolarizations of ethyl-[1-13C]pyruvate, hydrogen-
ated using ParaHydrogen, have been compared to those
observed on the more widely used allyl-derivative. It has been
demonstrated that the spin order transfer from ParaHydrogen
protons to 13C, is more efficient on the ethyl than on the allyl-
esterdue to the larger J-couplings involved. The main require-
ments needed for the biological application of this HP product
have been met, i. e. an aqueous solution of the product at high
concentration (40 mM) with a good 13C polarization level (4.8%)
has been obtained. The in vitro metabolic transformation of the
HP ethyl-[1-13C]pyruvate, catalyzed by an esterase, has been
observed. This substrate appears to be a good candidate for
in vivo metabolic investigations using PHIP hyperpolarized
probes.
1. Introduction
The access to hyperpolarization techniques has brought an
outstanding contribution in the perspectives of providing
innovative tools in the field of medical diagnoses as it allows,
for the first time, the investigation of metabolic processes
in vivo, in real time.[1–3] Dissolution-Dynamic Nuclear Polarization
(d-DNP)[3,4] is the gold standard among the hyperpolarization
methods and several in-human studies are currently
ongoing,[6–10] that aim to translate this powerful diagnostic tool
to the clinics. In spite of the important achievements, the
distribution of d-DNP in clinical settings appears hampered by
the high cost and the technical complexity of the technique as
well as by the intrinsically slow polarization time. On this basis
much attention is still devoted to the alternative approach to
hyperpolarize molecules based on ParaHydrogen Induced Polar-
ization (PHIP)[11–13] because this technique is simpler, faster, and
cheaper than d-DNP. Moreover, the Side-Arm Hydrogenation
(SAH) strategy (PHIP-SAH)[14] has extended the PHIP substrate
scope to a number of biologically relevant molecules for which
an unsaturated ParaHydrogen acceptor was not available.[15]
Currently, among the applications of the PHIP-SAH approach,
the access to HP pyruvate is obviously the one on which the
attention is more focussed and metabolic studies in vivo and in-
cells have been reported.[16–18] This strategy can, in principle, be
applied to any molecule containing a carboxylic group and is
based on the esterification of the target substrate with an
unsaturated alcohol. The unsaturated ester is, then, hydro-
genated using hydrogen enriched in the para-isomer, the spin
order of ParaHydrogen is transferred to 13C and the ester is
hydrolysed to obtain the 13C hyperpolarized product.
The use of propargylic esters is convenient, thanks to the
simple synthetic route and because triple bonds can be
hydrogenated easily. Aqueous solutions of HP [1-13C]pyruvate
thus obtained have already been used for in vivo and in-cells
studies.[16–18] Vinyl esters have also been synthesized and
hydrogenated using ParaHydrogen,[19–22] nevertheless the con-
ditions in which they were obtained (organic solvents, low
concentration) are not suitable for biological applications.
Furthermore, the synthesis of vinyl-[1-13C]pyruvate shows more
challenges than other metabolites, due to the intrinsic insta-
bility of this molecule.
In this work we report an efficient synthetic procedure for
vinyl-[1-13C]pyruvate from which hyperpolarized ethyl-[1-13C]
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pyruvate can be obtained by means of the PHIP procedure.
Ethyl-pyruvate is able to cross the BBB (blood-brain barrier)
with greater efficiency than pyruvate and this substrate, hyper-
polarized by means of the d-DNP procedure, was used as a
metabolic probe in the brain, to investigate the occurrence of
neurological pathologies in which metabolism is
dysregulated.[23,24] The application of HP substrates to biological
studies requires that an aqueous solution of the HP product is
obtained, endowed with sufficiently high concentration and
good hyperpolarization level. All these issues will be tackled, in
this work, and the differences between 13C hyperpolarization in
allyl- and ethyl- esters will be discussed.
2. Results and Discussion
2.1. Synthesis of Vinyl-[1-13C]pyruvate
Vinyl esters cannot be obtained through direct esterification of
the alcohol with the acid (the so-called Fischer esterification),
due to the unfavorable keto-enol equilibrium between the vinyl
alcohol and the more stable acetaldehyde, and they can be
obtained through trans-vinylation reactions between the
carboxylic acid and vinyl esters (usually, vinyl-acetate).[25,26]
Unfortunately, pyruvic acid solutions are rather unstable,
and it is well-known that this α-ketoacid quickly forms dimers
and oligomers, especially at high temperature and alkaline
pH.[27] Due to this reason, the trans-vinylation reaction of
pyruvic acid with vinyl acetate,[19,28] led, in our hands, to the
quick degradation of the substrates, that made impossible the
isolation of the desired product from the reaction mixture.
Although the reaction yields might be improved by the use of a
larger amount of the starting material, this way could not be
conveniently pursued for the synthesis of the isotopically
enriched vinyl-[1-13C]pyruvate, on a laboratory scale.
Therefore, we decided to overcome the intrinsic instability
of pyruvate by synthesizing a more stable ketal derivative
(Scheme 1, II).[29]
The ketalization of [1-13C]pyruvic acid (I) was obtained by
reaction with triethyl orthoformate (TEOF)[30] catalysed by
Nafion H®. In the original work,[31] sulfuric acid was used to
catalyse the reaction, but, in this case, a not negligible amount
of ethyl-sulphate was formed, which is quite toxic and difficult
to remove from the desired product. Sulphonic resins were also
reported to be efficient acidic catalyst. Nafion H®, a sulfonated
tetrafluoroethylene based fluoropolymer-copolymer, with ex-
cellent thermal and mechanical stability, was proven to be the
most efficient, in our case, for the ketalization of pyruvic acid to
[1-13C]-2,2-diethoxypropanoic acid (II). It must be noticed that
the resin can be easily removed, together with the by-products,
by means of filtration and regenerated, after every use, in order
to make the process more cost effective.
Compound (II) was then reacted with vinyl acetate using
palladium diacetate as catalyst to obtain the vinyl ester (vinyl-
[1-13C]-2,2 diethoxypropanoate, III). To prevent the degradation
of the catalyst to metallic Pd, the complex was stabilized by
means of complexation with pyridine. As transvinylation is a
reversible reaction with an equilibrium constant near to one,
this feature appears as the limiting step in terms of obtainable
yields. Finally, vinyl-[1-13C]-2,2diethoxypropanoate (III) was de-
protected using an excess of trifluoroacetic acid (TFA)[32] in
dichloromethane (DCM). This route to obtain the deketalization
was chosen to reduce as much as possible the presence of
ethanol in the solution, which may yield subsequent trans-
esterification with pyruvate. In the applied experimental design,
volatile ethyl trifluoroacetate was formed, which was easily
removed together with the solvent by evaporation in vacuum,
to yield vinyl-[1-13C]pyruvate (IV). The overall yield of the
process, in terms of transformation of 13C-labelled pyruvate into
13C-labelled vinyl pyruvate, was 8.3%. To the best of our
knowledge, this is the first time that vinyl [1-13C]pyruvate is
obtained in amounts and form suitable for a detailed study of
its hyperpolarization properties, as described below.
2.2. ParaHydrogen Hyperpolarization
Parahydrogenation of vinyl-[1-13C]pyruvate has been carried
out, then, to obtain 13C hyperpolarized ethyl-pyruvate. Thanks
to the larger J-couplings among the added ParaHydrogen
protons and the 13C carboxylate spin, we might expect a more
efficient spin order transfer from protons to 13C with respect to
parahydrogenated allyl-[1-13C]pyruvate. The relationship be-
tween the efficiency of spin order transfer (SOT) with the
strength of proton-carbon J-couplings has already been dis-
cussed, for a simple three spins system.[33] Therefore, we
deemed useful to compare the PHIP response of vinyl-[1-13C]
pyruvate with the one provided by propargyl-[1-13C]pyruvate.
The hyperpolarization experiments were carried out by
means of hydrogenation, using para-enriched hydrogen in
chloroform solution using the commercial rhodium catalyst
[1,4-Bis(diphenylphosphino)butane](1,5-cyclooctadiene)
rhodium(I) tetrafluoroborate ([Rh(COD)dppb][BF4], CAS: 79255-
71-3).
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The hydrogenation reactions were carried out in an NMR
sample tube equipped with a valve (Norell®), pressurized with
ParaHydrogen. To initiate the hydrogenation reaction, the NMR
tube was heated in a hot water bath at 85 °C for about 7 s, then
shaken vigorously for 3 s.
In order to transform the proton spin order derived from
the addition of ParaHydrogen into net 13C magnetization,
magnetic field cycling (MFC)[34,16] was applied. To do that, the
NMR sample tube containing the parahydrogenation product
was placed in the μ-metal shield, immediately after the release
of the ParaHydrogen pressure at the end of the reaction. The μ-
metal shield is equipped with a solenoid coil fed with controlled
current which enables a precise control of the magnetic field
variations that occur during the MFC[35] procedure (see S.I. for
more details). The field, initially set at 1.5 μT, was suddenly
dropped to 150 nT in less than 1 ms, then increased exponen-
tially to 10 μT in 4 s; the obtained 13C polarization was 3.8�
0.3% (Table 1). When the 13C hyperpolarization experiment was
carried out on the propargyl ester, using an exponential
remagnetization that starts from 50 nT, about 6.2�0.3% 13C
hyperpolarization was obtained on allyl-[1-13C]pyruvate. The
higher 13C polarization measured on the allyl-ester, in respect to
the one on the ethyl-ester, might appear in contrast with the
fact that the J-couplings, between the added ParaHydrogen
protons and the 13C carboxylate atom, are larger for the second
spin system (Figure 1) and the spin order transfer should be
more efficient.
We surmise that the observed heteronuclear hyperpolariza-
tion level depends on the 1H spin order obtained on the
product, upon the addition of ParaHydrogen to the substrate.
1H hyperpolarization was assessed by carrying out ALTADENA
experiments.[36,13] In these experiments, hyperpolarized 1H-NMR
spectra were acquired 18 s after the completion of the para-
hydrogenation reaction, carried out at the geomagnetic field.
The typical ALTADENA pattern of hyperpolarized signals was
observed (Figure 2) for the methylene and methyl groups of
ethyl-pyruvate resulting in a proton polarization level of 2.4�
0.4%.
Conversely, when the ALTADENA experiment was carried
out using propargyl-[1-13C]pyruvate, the 1H hyperpolarized
signals were outstandingly intense and the spectrum was
characterized by damped signals. The proton polarization was
measured to be 6.0�0.1%.
It might be surprising that the hyperpolarization observed
on protons is lower than that on 13C. This occurs because the
delay between the end of the hydrogenation and the
acquisition of the 1H hyperpolarized spectrum, in the ALTADE-
NA experiment, is much longer than that between the hydro-
genation end and the application of the MFC. Therefore, the
spin order loss, due to relaxation, is much more prominent in
the first than in the second case. Anyway, the ALTADENA
experiments clearly show that the proton spin order is
significantly smaller on the ethyl rather than on the allyl
derivative (2.4% on the ethyl vs 6.0% on the allyl ester)
(Table 1). Conversely, the difference between 13C polarization of
the two esters, is much less relevant (3.8% on the ethyl vs.
6.2% on the allyl) (Table 1). From these results one may draw
Table 1. 1H and 13C polarization level of ethyl- and allyl-[1-13C]pyruvate at






Figure 1. 1H-13C J-couplings of ethyl-[1-13C]pyruvate and allyl-[1-13C]pyruvate
measured in the reaction solution after the parahydrogenation of the
precursors.
Figure 2. 1H-NMR spectra of parahydrogenated ethyl-[1-13C]pyruvate and propargyl-[1-13C]pyruvate obtained in ALTADENA experiments. The proton
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the conclusion that the spin order transfer from the Para-
Hydrogen protons to 13C net magnetization is more efficient on
the ethyl rather than on the allyl ester, thanks to the larger J-
couplings, as expected from the theory. Due to this reason, we
can also hypothesize that the application of pulsed Spin Order
Transfer (SOT) methods,[33,37,38] at high field, may lead to efficient
hyperpolarization of the 13C signal.
The smaller 1H hyperpolarization observed on the para-
hydrogenated ethyl ester may be due to the lower hydro-
genation efficiency of a double bond with respect to a triple
bond, in homogeneously catalyzed reactions, as was already
noticed in previous studies.[15] Metal complexes of the type
[Rh(diene)Ln], (Ln can be a mono-dentate (n=2) or a bi-dentate
(n=1) ligand) catalyse the hydrogenation of alkynes to alkenes
much faster than the subsequent hydrogenation of alkenes to
alkanes.[39] Even if the slower hydrogenation of the vinyl-
derivative cannot be appreciated in our experiments, as
complete hydrogenation is achieved in few seconds, a slower
reaction implies the formation of more stable intermediates, on
which the singlet state of ParaHydrogen is mixed with the
triplet states.[40] Therefore, the population of the singlet state is
depleted and the hyperpolarization level on the products is
decreased.
Furthermore, the lower 1H hyperpolarization on the ethyl
ester may also be due to the different proton relaxation rates in
the ethylene and in the allyl groups (Table 2). The relaxation
rate of ParaHydrogen protons, measured at high magnetic field
in the NMR spectrometer, is about two times faster in the ethyl
than in the allyl ester. Nevertheless, it must be noticed that, at
geomagnetic field, where the hydrogenation takes place, the
relaxation processes might significantly differ from those
observed at high field.
2.3. 13C hyperpolarization in aqueous medium and enzymatic
reactions
For the intended biological applications, the hyperpolarized
ethyl-[1-13C]pyruvate has to be used in aqueous solution.
Therefore, vinyl-[1-13C]pyruvate (80 mM) was hydrogenated
using the water-soluble rhodium complex [Rh(NBD)L2]BF4 (L2 =
1,4-bis[(phenyl-3- propanesulfonate) phosphine] butane).[41] Fol-
lowing the reaction with ParaHydrogen, the solution underwent
MFC. The 13C-NMR spectra acquired immediately after the spin
order transfer step, showed 12.3�0.3% polarization on the 13C-
carboxylate signal of ethyl pyruvate, with a hydrogenation yield
of 55�3%. The higher polarization obtained in the aqueous
solvent might be attributed to a higher efficiency of the
catalyst. As clearly assessed from the 13C-NMR spectrum in
aqueous solution, the hydrated form of the ethyl-ester of
pyruvate is about 76% of the total amount, and its polarization
is 2.4�0.1%. The degree of hydration of the α-ketoacids is
sensitive to electronic/resonance effects and hydration is great-
er in the acidic form than in the carboxylate form,[42] therefore it
is not surprising that a high percentage of the ethyl-ester of
[1-13C]pyruvate is in the hydrated form, in a large range of pH.
Considering that the hydrated and non-hydrated forms of
ethyl-pyruvate are exchanging one with the other,[29] the
average 13C polarization of ethyl-pyruvate in aqueous solution is
4.8%.
The relaxation rate of ParaHydrogen protons was also
measured at high magnetic field, in the conditions of the
aqueous hydrogenation, and it resulted comparable to the
relaxation rate previously measured in CDCl3 (Table 3).
Finally, the esterase catalyzed conversion of the HP ethyl
ester to [1-13C]pyruvate was tested. The build-up of the signals
of [1-13C]pyruvate was clearly observed in the series of 13C-NMR
spectra acquired immediately after the addition of the HP-ester
to the enzyme containing solution (Figure 3). Conversely, no
transformation was observed when the solution of the HP
substrate was added to the HEPES buffer solution. However, we
have to remind that, albeit that early studies have shown low
toxicity of the hydrogenation catalyst,[43] the rhodium complex
would ideally be removed before the injection in-vivo.
3. Conclusions
13C labelled vinyl-ester of pyruvate has been obtained through
a synthetic pathway in which the intrinsic instability of this
metabolite has been circumvented thanks to the formation of
its ketalic form, that is more stable. This substrate has been
isolated and 13C hyperpolarization of ethyl-[1-13C]pyruvate has
been obtained, by means of ParaHydrogen, in both organic and
aqueous solutions. It has also been shown that the spin order
transfer, from the ParaHydrogen protons to the 13C carboxylate
spin, is more efficient in the parahydrogenated ethyl-[1-13C]
pyruvate than in the allyl-[1-13C]pyruvate derived from para-
hydrogenation of the propargyl-ester. This is due to the larger
J-couplings involved in the ethyl- rather than in the allyl-
derivative.
PHIP polarized ethyl-[1-13C]pyruvate obtained at high con-
centration (40 mM) and good polarization level (4.8%) in
aqueous solution, allowed to demonstrate the conversion of HP
ethyl-[1-13C]pyruvate into [1-13C]pyruvate by a buffered solution
of esterase.
Table 2. T1 of protons in CDCl3 hydrogenation conditions, measured at
9.4T.









Table 3. T1 of protons in aqueous hydrogenation conditions, measured at
9.4T.
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All these features made this ParaHydrogen hyperpolarized
molecule suitable for biological applications and a promising
candidate for in-vivo metabolic studies, thus widening the
scope of PHIP polarized substrates.
Experimental Section
[1-13C]pyruvic acid was purchased from CortecNet. All other
chemicals were purchased from Merck KGaA and were used
without purification. All the NMR spectra of the synthesized
materials were acquired at 14.1T using a 600 MHz Bruker Avance
NMR spectrometer.
Synthesis of Vinyl-[1-13C]pyruvate
The synthesis pathway is described in Scheme 1.
[1-13C]-2,2-diethoxypropanoic acid (II) The [1-13C]pyruvic acid (CAS:
99124-30-8) (2 g; 22.45 mmol) was dissolved in triethyl orthofor-
mate (TEOF) (CAS: 122-51-0) (10 ml; 57 mmol) and was cooled to 0–
5 °C with an ice bath; 200 mg of Nafion H® resin were added and
the reaction was stirred at room temperature under argon
atmosphere. After 2 h and after 5 h, 120 mg of Nafion H® resin and
4 ml of TEOF were added. After one night, the mixture was filtered
and 25 ml of DCM were added: the organic solution was washed
with water (3×12 ml); the aqueous phase was extracted with DCM
(12 ml). All the organic phases were put together, washed with
brine (12 ml), dried over Na2SO4 and evaporated to residue (3.1 g,
yield 85%). 1H NMR (600 MHz, CDCl3): δ=1.24 (t, 6H, J=7.08 Hz),
1.57 (d, 3H, J=3.45 Hz), 3.55 (m, 4H). 13C NMR (400 MHz, CDCl3): δ=
15.24 (2C), 21.78 (1C), 58.79 (2C), 99.75 (d, 1C, J=67.29 Hz), 171.07
(1C).
[1-13C]-2,2-diethoxypropanoic acid vinyl ester (III) The [1-13C]-2,2-
diethoxypropanoic acid (II) (3.1 g; 19 mmol) was dissolved in vinyl
acetate (CAS: 108-05-4) (24 ml; 0.26 mol); freshly prepared
[pyridine]2Pd(AcO)2
[44] (40 mg; 0.1 mmol) was added every 4 hours
for a total of 280 mg; the third day a little amount of NaAcO was
added, the solution was filtered and washed with NaAcO 10% (3×
20 ml) and brine (20 ml). The solution was evaporated at 25 °C and
100 mbar then the product was distilled at 50 °C and 18 mbar with
a Claisen apparatus and the collection flask cooled to   80 °C.
(788 mg; 85% w/w pure, yield 19%; the impurity is represented by
the ethyl ester). 1H NMR (600 MHz, CDCl3): δ=1.24 (t, 6H, J=
6.96 Hz), 1.58 (d, 3H, J=3.38 Hz), 3.47–3.64 (m, 4H), 4.68 (d, 1H, J=
6.29 Hz), 5.02 (d, 1H, J=13.89 Hz), 7.29 (ddd, 1H, J=2.5 – 6.29–
13.89 Hz). 13C NMR (600 MHz, CDCl3): δ=15.34 (2C), 22.00 (1C),
58.34 (2C), 99.3 (1C), 141.29 (1C), 167.46 (1C).
Vinyl-[1-13C]pyruvate (IV) The [1-13C]-2,2-diethoxypropanoic acid
vinyl ester (III) (788 mg; 3.56 mmol) was dissolved in DCM (25 ml),
cooled to 0 °C with an ice bath and trifluoroacetic acid (TFA) (6.3 ml;
84 mmol) was added. The reaction was followed by means of NMR
and after 2 h at room temperature the deprotection was complete.
The organic solution was gently dropped into NaHCO3 5%,
vigorously stirred, keeping the pH 6–7 by adding NaHCO3 5%. The
organic phase was separated from the aqueous one and evapo-
rated at 25 °C and 400 mbar. The product was distilled at 40 °C and
18 mbar with a Claisen apparatus and the collection flask cooled to
  80 °C. Compound (IV) was recovered (376 mg 55.7%w/w pure,
yield 51%. Ethyl pyruvate, 11.9% w/w, and dichloromethane,
32.4%w/w, are the only impurities, but they do not affect polar-
ization experiments. Nevertheless, their amount is taken in account
for the evaluation of the signal enhancement). The overall yield of
the process, in terms of transformation of 13C-labelled pyruvate into
13C-labelled vinyl pyruvate was 8.3%. 1H NMR (600 MHz, CDCl3): δ=
2.52 (d, 3H, J=1.42 Hz), 4.82 (dd, 1H, J=2.10–6.14 Hz), 5.17 (dd, 1H,
J=2.10–13.70 Hz), 7.28 (ddd, 1H, J=2.10 – 6.14–13.70 Hz). 13C NMR
(600 MHz, CDCl3): δ=26.79 (d, 1C, J=17.3 Hz), 101.41 (1C), 140.70
(1C), 157.56 (1C).
Synthesis of Propargyl-[1-13C]pyruvate
The synthesys pathway is reported in Scheme 2.
Propargyl-[1-13C]pyruvate (V) [1-13C]pyruvic acid (2 g; 22.45 mmol)
was dissolved in propargyl alcohol (CAS: 107-19-7) (6.52 ml;
113 mmol) and cooled to   10 °C with an ice/NaCl bath; H2SO4 conc.
(1.58 ml; 29.6 mmol) was slowly added dropwise, then the reaction
was stirred at room temperature under argon atmosphere for
2 days. The mixture was then cooled in ice and 8 ml of water were
Figure 3. (A) Series of 13C-NMR spectra acquired upon mixing the pyruvate esterase containing solution (400 U) with the aqueous solution of hyperpolarized
ethyl-[1-13C]pyruvate. Spectra were acquired using small flip angle pulse (10°) and 2 s delays between successive scans. (B) expanded 13C-NMR spectrum at
maximum intensity of the [1-13C]pyruvate signal; (C) Plot of the time dependent changes of the signals of ethyl-[1-13C]pyruvate, its hydrated form, and of the
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added; the product was extracted with DCM (3×8 ml), washed with
water (8 ml), NaHCO3 10% (3×8 ml) and brine (8 ml). The organic
layer was evaporated at room temperature and the product was
distilled with the Hickman apparatus at 80–110 °C 33 mbar (1.18 g,
yield 42%). 1H NMR (600 MHz, CDCl3): δ=2.50 (d, 3H, J=1.48 Hz),
2.55 (t, 1H, J=2.56 Hz), 4.84 (t, 2H, J=2.94 Hz). 13C NMR (600 MHz,
CDCl3): δ=26.9 (d, 1C, J=16.9 Hz), 53.75 (d, 1C, J=2.71), 76.24 (1C),
76.40 (1C), 159.83 (1C), 190.85 (d, 1C, J=67.14 Hz).
13C Hyperpolarization of Ethyl- and Allyl-[1-13C]pyruvate
The hyperpolarization experiments were carried out by means of
hydrogenation, using para-enriched hydrogen (Bruker BPHG gen-
erator, 85% enrichment), of the substrates (200 mM) in chloroform
solution (100 μl CDCl3), catalysed by the commercial rhodium
complex [Rh(COD)dppb][BF4] (13.8 mM). Ethanol (5 μl, 85 mM) was
also added, as hydrogenation co-solvent, in order to increase the
polarization level.
The hydrogenation reactions were carried out in a NMR sample
tube equipped with a valve (Norell®). ParaHydrogen (2 bar) was
added to the NMR tube by keeping it in a liquid nitrogen bath. To
initiate the hydrogenation reaction, the NMR tube was heated in a
hot water bath at 85 °C for 7 s, then shaken vigorously for 3 s. The
tube was opened to release the ParaHydrogen pressure and placed
in the μ-Metal shield for the application of the MFC. Then it was
quickly placed in the 400 MHz NMR spectrometer (Bruker Avance
III) and a 90° pulse was applied at the 13C NMR frequency, after the
addition of 250 μl of CDCl3 (added to obtain an adequate volume
for the acquisition of a 13C-NMR spectrum). 13C polarization has
been referred to the thermal spectra acquired on each hyper-
polarized sample (6 transients, inter-scan delay 300 s) and the
ParaHydrogen enrichment was not used to normalize the results.
1H Hyperpolarization of Ethyl- and Allyl-[1-13C]pyruvate
The hydrogenation was carried out under the same conditions
reported for 13C HP. Immediately after hydrogenation completion,
the NMR tube was opened to release the ParaHydrogen pressure
and CDCl3 was added (250 μl) in order to obtain an adequate
volume for the acquisition of a 1H-NMR spectrum. Then the tube
was quickly placed in the 400 MHz NMR spectrometer (Bruker
Avance III) and a 90° pulse was applied at the proton NMR
frequency. The time lapse between the end of the hydrogenation
step and the acquisition of the 1H-NMR spectrum was 18 s.
13C Hyperpolarization in Aqueous Medium and Enzymatic
Reactions
The substrate vinyl-[1-13C]pyruvate was hydrogenated using the
water-soluble rhodium complex [Rh(NBD)L2]BF4 (L2=1,4-bis
[(phenyl-3- propanesulfonate) phosphine] butane). In these experi-
ments, the NMR tubes were charged with the catalyst solution
(300 μl, 5 mM in D2O) and the substrate (80 mM). When para-
hydrogenation was completed, the NMR tube was opened to
release the ParaHydrogen pressure, placed in the μ-Metal shield,
MFC was applied and then it was quickly placed in the 600 MHz
NMR spectrometer (Bruker Avance III) for the acquisition of the 13C
NMR spectrum.
To observe the enzyme catalyzed conversion to [1-13C]pyruvate,
300 μl of a buffered solution of esterase (60–400 U in 100 μl HEPES
buffer, pH 6.5) was placed in the NMR spectrometer and kept at
25 °C. The aqueous solution of 13C hyperpolarized ethyl pyruvate
was prepared as described in the previous paragraph, collected in a
syringe containing 100 μl of HEPES (430 mM) and immediately
injected into the enzyme solution by means of a PTFE tube, using a
set-up already described.[39]
Using this procedure, the final pH of the hyperpolarized aqueous
solution was 6.5–7. At this pH the hydrate form of ethyl-[1-13C]
pyruvate correspond to 74–77% of the total ethyl-pyruvate in the
aqueous solution, and this percentage does not change over a pH
range from 1.5 to 7, as shown in the S.I.
MFC Setup
To perform the MFC, after the hydrogenation, the tube was
immediately placed in a three-layers μ-Metal shield (Aspect
Imaging, Shoham, Israel). The complete magnetic field cycling is
obtained by controlling the current in a coaxial solenoid by means
of a custom-written function (Microsoft Visual Basic) that drives an
Arbitrary Waveform Generator (Keysight Technologies 33220A
20 MHz, Keysight Technologies, Santa Rosa, U.S.). The sample was
then lifted out of the shield and placed in the NMR spectrometer
for the acquisition of the 13C-NMR spectrum.
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ARTICLES
13C hyperpolarized ethyl-[1-13C]
pyruvate by means of PHIP-SAH:
Vinyl-[1-13C]pyruvate has been
prepared on laboratory scale through
a new synthesis route. After its hy-
drogenation with p-H2 and magnet-
ization transfer (via MFC), polarized
ethyl-[1-13C]pyruvate has been
obtained in aqueous solution at high
concentration (40 mM) and good po-
larization level (4.8%). In the end, the
in-vitro conversion of HP ethyl-[1-13C]
pyruvate into [1-13C]pyruvate
catalysed by an esterase, has been
observed.
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